Your browser doesn't support javascript.
loading
Fecal Microbiota Transplantation (FMT) as an Adjunctive Therapy for Depression-Case Report.
Doll, Jessica P K; Vázquez-Castellanos, Jorge F; Schaub, Anna-Chiara; Schweinfurth, Nina; Kettelhack, Cedric; Schneider, Else; Yamanbaeva, Gulnara; Mählmann, Laura; Brand, Serge; Beglinger, Christoph; Borgwardt, Stefan; Raes, Jeroen; Schmidt, André; Lang, Undine E.
Afiliación
  • Doll JPK; Department of Psychiatry (UPK), University of Basel, Basel, Switzerland.
  • Vázquez-Castellanos JF; Department of Microbiology and Immunology, Rega Institute for Medical Research, KU Leuven-University of Leuven, Leuven, Belgium.
  • Schaub AC; Department of Psychiatry (UPK), University of Basel, Basel, Switzerland.
  • Schweinfurth N; Department of Psychiatry (UPK), University of Basel, Basel, Switzerland.
  • Kettelhack C; Department of Psychiatry (UPK), University of Basel, Basel, Switzerland.
  • Schneider E; Department of Psychiatry (UPK), University of Basel, Basel, Switzerland.
  • Yamanbaeva G; Department of Psychiatry (UPK), University of Basel, Basel, Switzerland.
  • Mählmann L; Department of Psychiatry (UPK), University of Basel, Basel, Switzerland.
  • Brand S; Center for Affective, Stress- and Sleep Disorders (ZASS), Psychiatric Clinics (UPK), University of Basel, Basel, Switzerland.
  • Beglinger C; Sleep Disorders Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Borgwardt S; Substance Abuse Prevention Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Raes J; Division of Sport Science and Psychosocial Health, Department of Sport, Exercise, and Health, University of Basel, Basel, Switzerland.
  • Schmidt A; Department of Psychiatry, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Lang UE; Department of Research, St. Clara Hospital, Basel, Switzerland.
Front Psychiatry ; 13: 815422, 2022.
Article en En | MEDLINE | ID: mdl-35250668
ABSTRACT
Depression is a debilitating disorder, and at least one third of patients do not respond to therapy. Associations between gut microbiota and depression have been observed in recent years, opening novel treatment avenues. Here, we present the first two patients with major depressive disorder ever treated with fecal microbiota transplantation as add-on therapy. Both improved their depressive symptoms 4 weeks after the transplantation. Effects lasted up to 8 weeks in one patient. Gastrointestinal symptoms, constipation in particular, were reflected in microbiome changes and improved in one patient. This report suggests further FMT studies in depression could be worth pursuing and adds to awareness as well as safety assurance, both crucial in determining the potential of FMT in depression treatment.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Front Psychiatry Año: 2022 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Front Psychiatry Año: 2022 Tipo del documento: Article País de afiliación: Suiza